Oxygen radicals and oxidant stress toxicity have been causally linked to convulsions (grand mal seizures) that are life-threatening and limit the oxygen pressure that can be used in HBO therapy, the treatment of choice for gas gangrene and CO poisoning. Neurodegenerative diseases including Huntington's and amyotrophic lateral sclerosis and brain trauma and stroke have also been linked to oxygen radical toxicity mechanisms. Convulsions can be caused by excessive stimulation of excitatory neuronal receptors which also can kill neuronal cells. Quinolinic acid (QA), a metabolite of the brain kynurenine pathway from tryptophan, is the most potent endogenous excitatory and convulsive agent known, 100-X as potent as aspartate or glutamate. QA is produced in glial cells by the kynurenine pathway which includes 3-hydroxyanthranilate oxidase (HAO), the immediate producer of QA. Oxygen and superoxide are substrates, and stimulatory, for 3 pathway enzymes including HAO which requires Fe 2 + and which we have found is also inactivated by HBO. QA has been measured and found to be elevated in brain and cerebrospinal fluid in the above named neurodegenerative disorders.
The Specific Aims are focused on the thesis that HBO convulsions are caused by imbalances in production and accumulation of QA and other kynurenine pathway intermediates via effects on oxygen and iron requiring enzymes. We will convulse rats in 5 atm HBO and also study their tissues and enzymes in vitro to elucidate biochemical and toxicologic mechanisms of oxygen on the kynurenine pathway. For the in vivo work, brain microdialysis probes and high performance liquid chromatography will be used to collect and quantify fluxes of kynurenine pathway intermediates prior to, during, and after convulsions (while in the HBO chamber) under a variety of test conditions. We also will use brain slices, homogenates and glial cell primary cultures to determine the effects of oxygen (including hyperbaric) tensions, iron, and ascorbate on Km and Vmax of pathway enzymes and fluxes of intermediates through the pathway. Correlated with the latter, we also will pursue the thesis that control of Fe2+ is critical to prevent oxidative inactivation of pathway enzymes. Better understanding of oxygen- and iron-regulation of the production of QA and other receptor agonists and antagonists pathway intermediates may allow development of specific strategies for their control in hyperbaric oxygen therapy and in neurodegenerative brain disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES002566-16
Application #
2796635
Study Section
Toxicology Subcommittee 2 (TOX)
Project Start
1995-09-30
Project End
2000-09-29
Budget Start
1998-09-30
Budget End
1999-09-29
Support Year
16
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Missouri-Columbia
Department
Miscellaneous
Type
Other Domestic Higher Education
DUNS #
112205955
City
Columbia
State
MO
Country
United States
Zip Code
65211
Dale, W E; Dang, Y; Amiridze, N et al. (2000) Evidence that kynurenine pathway metabolites mediate hyperbaric oxygen-induced convulsions. Toxicol Lett 117:37-43
Dang, Y; Dale, W E; Brown, O R (2000) Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway. Free Radic Biol Med 28:615-24
Dale, W E; Dang, Y; Brown, O R (2000) Tryptophan metabolism through the kynurenine pathway in rat brain and liver slices. Free Radic Biol Med 29:191-8
Dang, Y; Dale, W E; Brown, O R (2000) Effects of oxygen on kynurenine-3-monooxygenase activity. Redox Rep 5:81-4
Amiridze, N; Dang, Y; Brown, O R (1999) Hydroxyl radicals detected via brain microdialysis in rats breathing air and during hyperbaric oxygen convulsions. Redox Rep 4:165-70
Dang, Y; Xia, C; Brown, O R (1998) Effects of oxygen on 3-hydroxyanthranilate oxidase of the kynurenine pathway. Free Radic Biol Med 25:1033-43
Xia, C; Dang, Y; Brown, O R (1998) HPLC analysis of quinolinic acid, a NAD biosynthesis intermediate, after fluorescence derivatization in an aqueous matrix. Microbios 94:167-81
Brown, O R; Smyk-Randall, E; Draczynska-Lusiak, B et al. (1995) Dihydroxy-acid dehydratase, a [4Fe-4S] cluster-containing enzyme in Escherichia coli: effects of intracellular superoxide dismutase on its inactivation by oxidant stress. Arch Biochem Biophys 319:10-22
Amash, H S; Brown, O R; Padron, V A (1995) Protection by selective amino acid solutions against doxorubicin induced growth inhibition of Escherichia coli. Gen Pharmacol 26:983-7
Flint, D H; Smyk-Randall, E; Tuminello, J F et al. (1993) The inactivation of dihydroxy-acid dehydratase in Escherichia coli treated with hyperbaric oxygen occurs because of the destruction of its Fe-S cluster, but the enzyme remains in the cell in a form that can be reactivated. J Biol Chem 268:25547-52

Showing the most recent 10 out of 15 publications